Visit COVID-19 resources

[Skip to Content]

Pirfenidone inhibits post-traumatic proliferative vitreoretinopathy – (Eye 31, 1317 (September 2017))

14 September 2017

This news item is available to RCOphth members only, please log in below to access.

Members Login